Webinars
GEN Magazine Webinar: Shifting Cell-Line Development into High Gear
Speakers:
Richard Visconti, Senior Research Biologist, In Vitro Sciences, Cell Production Group, Merck & Co.
Darren Cawkill, Ph.D., Senior Principal Scientist, Pfizer Global Research and Development
Fredrik Kamme, Ph.D., Senior Scientist, Applications Development, Cyntellect
Abstract
Many scientists depend on stably transfected cell lines for cell-based compound-screening applications. However, in the process of developing novel assays for high-throughput screening, creating the appropriate cell line usually turns out to be the main bottleneck. The current economic environment, within which the pharmaceutical industry finds itself, calls for a better approach to cell-line development. Slow, manual, and iterative procedures need to be replaced by faster and automated systems that offer more efficiency and predictability. This GEN webinar will not only show you how to improve the cell-line development process but also provide you with what you need to know about the revolutionary technologies and approaches that are available to shift your high throughput screening activities for drug discovery into high gear.
Featured Applications
Automated In Situ Purification
Automated in situ purification of primary rat brain microvascular endothelial cells
siRNA Optoinjection and Knockdown
Optoinjection of siRNA and functional knockdown of erythropoietin receptor in primary human CD34+ cells
Support
Commitment to Our Customers
Experienced scientific and technical customer support teams are ready to advise with timely and professional assistance.
